Impact of COVID-19 on the hospitalization, treatment, and outcomes of intracerebral and subarachnoid hemorrhage in the United States

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

COVID-19: Involvement of the nervous system. Identifying neurological predictors defining the course of the disease

Managing multiple sclerosis in the COVID19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia

Amyotrophic lateral sclerosis caregiver burden and patients' quality of life during COVID-19 pandemic

Myalgia as a symptom at hospital admission by SARS-CoV-2 infection is associated to persistent musculoskeletal pain as long-term post-COVID sequelae: a case-control study

Impact of cerebral venous sinus thrombosis associated with COVID-19

Myelopathy associated with SARS-COV-2 infection. A systematic review

Drug treatments for COVID-19: living systematic review and network meta-analysis

Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study

Prevalence, clinical characteristics and outcomes of Guillain‐Barré syndrome spectrum associated with COVID‐19: a systematic review and meta‐analysis

Neuro‐COVID frequency and short‐term outcome in the northern Portuguese population

Increased Incidence of Functional (Psychogenic) Movement Disorders in Children and Adults Amidst the COVID-19 Pandemic: A Cross-Sectional Study

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection